Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), by Application (Research, Clinical Diagnostics), by End User (Hospitals, Pharmaceutical Industry & CROs, Academics, Others), by Geography– Global Forecast to 2020
Radioimmunoassay technique is basically used to measure the concentration of specific antigens by using specific antibodies. This technique is mainly used for research purposes rather than for diagnostics purposes. The global radioimmunoassay (RIA) market constituted 2.3% share of the global immunoassay market.
Radioimmunoassay has applications in the field of clinical diagnostics, and is used in hospitals, contract research organizations (CRO), laboratories, pharmaceutical companies, and others. It is used for the early detection and diagnosis of cancer; recognition of endocrinological disorders; and various other applications. Pharmaceuticals companies use the RIA techniques for drug testing. Radioimmunoassay also has it application in the research purpose, and contributed a share of 65.9% to the overall radioimmunoassay market in 2014.
The global radioimmunoassay market is expected to reach $428.4 million by 2020, at a CAGR of 3.5% during the forecast period from 2015 to 2020. The growing aging population and rise in the usage of radioimmunoassay technique in Oncology are the major factors influencing this market.
There are various application areas for RIA in research and diagnostics, which are infectious disease testing, endocrine testing, allergy testing, oncology testing, toxicology testing, and autoimmune disease testing. Out of all the application segments, oncology testing is the largest application segment, and is expected to hold the largest market share in the near future. The major reason behind these is the growth in the oncology market due to various factors, such as the increasing incidence rate of cancer, growth in aging population, urbanization with heavy pollution, and others.
The global radioimmunoassay market report studies the major regions, namely, North America, Europe, Asia, and the Rest of the World (RoW).
In 2015, Europe is estimated to account for the largest share of 35.1% in the global radioimmunoassay market. As radioimmunoassay is one of the key instruments used in the life sciences sector, increased investments in life sciences are expected to fuel the growth of the radioimmunoassay market in the region. However, the growth in the European radioimmunoassay market is driven by the outsourcing of drug discovery, rising government investments in life sciences, and increasing prevalence of infectious diseases as well as cancer in this region.
The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany), among others.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. All of these together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities of the global Radioimmunoassay (RIA) market.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.
The report provides insights on the following pointers:
- Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the Global Radioimmunoassay (RIA) market are provided. - Market Development: Comprehensive information about lucrative emerging markets is provided. The report also analyzes the markets for Radioimmunoassay (RIA) across various regions, exploit new distribution channels, new clientele base and different pricing policies. - Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the Global Radioimmunoassay (RIA) market is provided. Detailed description regarding the related and unrelated diversification pertaining to this market is also provided. - Competitive Assessment: An in-depth assessment of market shares and company share analysis of the key players forecasted till 2020 is provided. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies in the Radioimmunoassay (RIA) market.
Our reports have been used by over 10K customers, including:
Magnetic Beads Market by Magnetic Core (Ferrimagnetic and Superparamagnetic), Size (Less than 5 um, 5-20 um, 20-40 um, and 40 um & Above) and Application (Next-Generation Sequencing (NGS), Biomolecule Separation & Purification, Molecular & Immunodiagnostics, and Other): Global Opportunity Analysis and Industry Forecast, 2020–2027 The...
China In-Vitro Diagnostics (IVD) market is predicted to exceed US$ 21 Billion by 2027. China is a large and fast-growing in vitro diagnostics (IVD) market - in fact, only second to the United States in terms of value. Historically, large multinational companies have dominated IVD market in China; today, domestic companies such as Shanghai...
The in-vitro diagnostics market in Asia Pacific is expected to grow from US$ 13,729.8 million in 2019 to US$ 20,401.5 million by 2027; it is estimated to grow at a CAGR of 5.1% from 2020 to 2027. Incidence of chronic diseases such as cancers, chronic respiratory diseases, diabetes, and heart disease is growing due to biological risk factors,...
The in-vitro diagnostics market in Europe is expected to grow from US$ 15,973.0 million in 2019 to US$ 22,221.8 million by 2027; it is estimated to grow at a CAGR of 4.2% from 2020 to 2027. The in-vitro diagnostics market has accounted for a significant market share in the healthcare industry during the COVID-19 pandemic. The market growth...
The in-vitro diagnostics market in Middle East and Africa is expected to grow from US$ 2,675.1 million in 2019 to US$ 3,454.0 million by 2027; it is estimated to grow at a CAGR of 3.2% from 2020 to 2027. Aging population is vastly vulnerable to viral infections as well as chronic conditions. Diabetes in adults generates higher risk of functional...
The in-vitro diagnostics market in North America is expected to grow from US$ 26,981.2 million in 2019 to US$ 38,759.6 million by 2027; it is estimated to grow at a CAGR of 4.7% from 2020 to 2027. Aging population is vastly vulnerable to viral infections as well as chronic conditions. For instance, according to the research conducted by American...
The in-vitro diagnostics market in South and Central America is expected to grow from US$ 4,387.7 million in 2019 to US$ 5,820.0 million by 2027; it is estimated to grow at a CAGR of 3.6% from 2020 to 2027. Automation deals with the utilization of various intelligent systems with an aim to perform any operation with minimal human intervention....
BCR-ABL Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)
BCR-ABL Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics...
Human T-Lymphotropic Virus (HTLV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)
Human T-Lymphotropic Virus (HTLV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize...
In Vitro Diagnostics
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.